COMPAGNIE LOMBARD ODIER SCMA – Regeneron Pharmaceuticals, Inc. Transaction History
COMPAGNIE LOMBARD ODIER SCMA portfolio value:
$1.29M
portfolio value
COMPAGNIE LOMBARD ODIER SCMA quarter portfolio value change:
+16.53%
quarter
Regeneron Pharmaceuticals, Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | 0.00% | 0 shares | 181K | $688.87 | 1.88K | |
Q2 2022 | share | 0.00% | 0 shares | -200K | $591.13 | 1.88K | |
Q1 2022 | share | 0.00% | 0 shares | 125K | $698.42 | 1.88K | |
Q4 2021 | share | 0.00% | 0 shares | 50K | $642.51 | 1.88K | |
Q3 2021 | share | Increase | +75.70% | 810 shares | 540K | $605.18 | 1.88K |
Q2 2021 | share | Decrease | -8.94% | -105 shares | 42K | $558.54 | 1.07K |
Q1 2021 | share | Decrease | -12.96% | -175 shares | -96K | $473.14 | 1.17K |
Q4 2020 | share | Increase | +6.30% | 80 shares | -59K | $483.11 | 1.35K |
Q3 2020 | share | Increase | +28.28% | 280 shares | 94K | $559.78 | 1.27K |
Q2 2020 | share | Decrease | -16.10% | -190 shares | 41K | $623.65 | 990 |
Q1 2020 | share | Increase | +47.50% | 380 shares | 276K | $488.29 | 1.18K |
Q4 2019 | share | Decrease | -11.21% | -101 shares | 50K | $375.48 | 800 |
Q3 2019 | share | 0.00% | 0 shares | -32K | $277.4 | 901 | |
Q2 2019 | share | Decrease | -23.51% | -277 shares | -201K | $313 | 901 |
Q1 2019 | share | Decrease | -20.30% | -300 shares | -69K | $410.62 | 1.17K |
Q4 2018 | share | Increase | +5.57% | 78 shares | -14K | $373.5 | 1.47K |
Q3 2018 | share | 0.00% | 0 shares | 83K | $404.04 | 1.4K | |
Q2 2018 | share | Decrease | -4.11% | -60 shares | -20K | $344.99 | 1.4K |
Q1 2018 | share | Decrease | -2.21% | -33 shares | -58K | $344.36 | 1.46K |
Q4 2017 | share | Increase | 0.00% | 1.49K shares | 561K | $375.96 | 1.49K |
Q2 2017 | share | Decrease | -100.00% | -70 shares | -27K | $491.14 | 0 |
Q1 2017 | share | Increase | 0.00% | 70 shares | 27K | $387.51 | 70 |